Professor Paul Riley
Paul is BHF Professor of Regenerative Medicine and Director of the Institute of Developmental and Regenerative Medicine at the University of Oxford. His research interests span cardiovascular developmental biology and modelling congenital heart disease, …
Responsible research
We expect all research conducted across the MRC/BHF CoRE in Advanced Cardiac Therapies to be rigorous, trustworthy and open. Many aspects of our work will be shared openly, usually disseminated through this website, including key research outputs such as …
Jobs
REACT brings together researchers in a collaborative environment. Alongside our scientific aims, our ambition is to create a more inclusive and supportive research culture, in line with our co-developed ways of working . We place a strong emphasis on …
CLIPPER Regulates LPIN1-Mediated Mitochondrial Biogenesis and Heart Regeneration
Francesco Paolo Ruberto …
Trained Immunity and Cardiovascular Risk: An Immunological Perspective
Katherine A. Boden …
Studentships
We are not currently advertising any PhD studentships. …
Identifying early response RNA binding proteins in cardiac fibrosis
Giancarlo Forte …
Determining mechanisms of cardiomyocyte proliferation-driven vascularisation
Although survival rates after myocardial infarction (MI) have improved, permanent loss of heart muscle cells often results in progressive heart failure. Restoring blood supply through angiogenesis (the growth of new blood vessels) could protect vulnerable …
The Stem Cell Podcast: Healing hearts with macrophages
Daylon James …
Professor Dame Molly Stevens
Molly is the the John Black Professor of Bionanoscience at the University of Oxford, with joint appointments in the Departments of Physiology, Anatomy & Genetics and Engineering Science, and Deputy Director of the Kavli Institute for Nanoscience …